Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Carhart

Showing results (11-20 of 170) with videos related to

Pageof 17
Sort By:
The Lancet. Psychiatry|August 29, 2016
Question-based Drug Development for psilocybin - Authors' replyRobin L Carhart-Harris, David J Nutt
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 27, 2017
The Therapeutic Potential of Psychedelic Drugs: Past, Present, and FutureRobin L Carhart-Harris, Guy M Goodwin
The British Journal of Psychiatry : the Journal of Mental Science|March 3, 2017
Psychedelics and the science of self-experienceMatthew M Nour, Robin L Carhart-Harris
Brain : a Journal of Neurology|March 3, 2010
The default-mode, ego-functions and free-energy: a neurobiological account of Freudian ideasR L Carhart-Harris, K J Friston
International Review of Neurobiology|June 20, 2025
Human neuroimaging: fMRIMatthew B Wall, Robin L Carhart-Harris
Journal of Psychopharmacology (Oxford, England)|September 1, 2017
Serotonin and brain function: a tale of two receptorsR L Carhart-Harris, D J Nutt
Frontiers in Pharmacology|February 2, 2018
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant DepressionLeor Roseman, David J Nutt, Robin L Carhart-Harris
Pharmacology Research & Perspectives|June 26, 2024
Psychotomimetic compensation versus sensitizationAri Brouwer, Robin L Carhart-Harris, Charles L Raison
Current Drug Abuse Reviews|January 8, 2015
A qualitative report on the subjective experience of intravenous psilocybin administered in an FMRI environmentS Turton, D J Nutt, R L Carhart-Harris
Therapeutic Advances in Psychopharmacology|February 6, 2015
Drug models of schizophreniaHannah Steeds, Robin L Carhart-Harris, James M Stone
Pageof 17

Showing results (11-20 of 170) with videos related to

Sort By:
Pageof 17
The Lancet. Psychiatry|August 29, 2016
Question-based Drug Development for psilocybin - Authors' replyRobin L Carhart-Harris, David J Nutt
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 27, 2017
The Therapeutic Potential of Psychedelic Drugs: Past, Present, and FutureRobin L Carhart-Harris, Guy M Goodwin
The British Journal of Psychiatry : the Journal of Mental Science|March 3, 2017
Psychedelics and the science of self-experienceMatthew M Nour, Robin L Carhart-Harris
Brain : a Journal of Neurology|March 3, 2010
The default-mode, ego-functions and free-energy: a neurobiological account of Freudian ideasR L Carhart-Harris, K J Friston
International Review of Neurobiology|June 20, 2025
Human neuroimaging: fMRIMatthew B Wall, Robin L Carhart-Harris
Journal of Psychopharmacology (Oxford, England)|September 1, 2017
Serotonin and brain function: a tale of two receptorsR L Carhart-Harris, D J Nutt
Frontiers in Pharmacology|February 2, 2018
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant DepressionLeor Roseman, David J Nutt, Robin L Carhart-Harris
Pharmacology Research & Perspectives|June 26, 2024
Psychotomimetic compensation versus sensitizationAri Brouwer, Robin L Carhart-Harris, Charles L Raison
Current Drug Abuse Reviews|January 8, 2015
A qualitative report on the subjective experience of intravenous psilocybin administered in an FMRI environmentS Turton, D J Nutt, R L Carhart-Harris
Therapeutic Advances in Psychopharmacology|February 6, 2015
Drug models of schizophreniaHannah Steeds, Robin L Carhart-Harris, James M Stone
Pageof 17